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Abstract 
The study investigates the nutritional status of patients receiving 
radiotherapy for treatment of cancer in an outpatient setting. There were 
39 subjects who were divided into four study groups depending on the 
positon of their treatment field. Three patients received treatment to the 
head and neck area (HN), 17 patients were receiving abdomino-pelvic 
irradiation (AP), 15 received radiotherapy to the chest (C) and five 
received treatment to parts of the body not associated with the 
gastrointestinal tract (O). Anthropometric, clinical and dietary indicators 
of nutritional status were used, these included measurements of Body 
Mass Index and weight loss, a subjective questionnaire in which patients 
reported possible nutrition compromising side effects of treatment and a 
24 hour dietary recall to estimate energy and protein intakes before and 
after treatment. 
The anthropometric and dietary indicators altered little with treatment 
and did not indicate a change in nutritional status. The clinical indicators 
were most important in detecting changes in the nutritional status of the 
patients. Clinical indications of declining nutritional status differed 
between the study groups. The AP group was found to be likely to 
develop diarrhoea during the course of radiotherapy. The C group was 
found to be at high risk of developing dysphagia during treatment. The 
HN group was expected to suffer the most changes in clinical indicators 
such as anorexia, xerostomia, dysphagia and dysgeusia, however, the 
number of patients in the group was too small to draw any meaningful 
results. The study recommends that a number of indicators of nutritional 
status, including anthropometric, biochemical, clinical and dietary 
indicators should be used when assessing the nutritional status of cancer 
patients. 
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Background and Statement of the Problem 
In July, 1993, the newly opened Cancer Care Centre (CCC) at The St 
George Hospital, Kogarah, began treating its first radiotherapy 
outpatients. The CCC had employed a number of full time Allied Health 
staff including 1.5 Full Time Equivalent (FTE) Dietitians. The number of 
outpatients receiving radiotherapy was expected to be high (up to 85 per 
day) and a significant proportion of these patients were expected to 
encounter nutrition related problems as a consequence of the treatment. It 
was therefore believed that a screening mechanism would need to be 
developed and used, thereby enabling the Dietitians in the CCC to more 
efficiently identify, prioritise and treat those nutritionally at-risk 
individuals. 
This study was developed to describe the nutritional status of the 
outpatients prior to radiotherapy commencing and to describe the changes 
in nutritional status as the therapy progressed. Information about the 
nutritional status of the outpatients would be gathered using 
anthropometric, subjective and dietary measures. Comparisons of 
nutritional status between groups of patients with different cancer types 
and treatment sites would be made. It was hoped that this information 
could be used to develop parameters for screening patients to identify 
potential nutritional problems before therapy commenced. This was 
expected to achieve minimisation of the impact of radiotherapy on the 
patient's nutritional status. 
Definition of Terms 
'Cachexia' from the Greek words kakos, meaning 'bad' and hexis, meaning 
'condition'. A syndrome in which patients with malignant disease 
develop anorexia, weakness and severe weight loss which greatly 
contributes to the morbidity and mortality of such patients. 
'Radiotherapy' The use of radiation (such as x-rays) in the treatment of 
Cancer and other diseases. 
'Gray' The SI unit of absorbed radiation dose, equal to the transfer of 1 
joule of energy per kilogram of absorbing material. 
'Fraction' The total radiation dose administered to a patient is divided 
into smaller doses called fractions. 
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Chapter 2 
Literature Review 
2.1 Introduction 
The term 'cancer' encompasses a group of neoplastic disorders which are 
characterised by transformation of normal cells into malignant ones. 
There is often a marked decline in the nutritional status of patients with 
cancer (Torosian and Daly, 1986). This deterioration in nutritional status 
can be caused by the disease itself, the effects of the treatment of the 
disease or a combination of these factors (Donaldson and Lenon, 1979). 
The most common treatments for cancer are surgery, chemotherapy and 
radiotherapy, all of which can have an impact on the patient's nutritional 
status (Kokal, 1985). This project is concerned with how radiotherapy 
treatment affects the nutritional status of cancer patients. 
2.2 Cancer Cachexia 
Cancer cachexia is a syndrome which is characterised by anorexia, severe 
weight loss, tissue wasting, early satiety and weakness. Cachexia is 
driven by the presence of a tumour and the effects of cachexia are 
reversed by removal of the tumour (Norton, et al., 1985). In 1932, Warren 
noticed a relationship between wasting and mortality in postmortem 
examinations of cancer patients. He concluded that cachexia was the most 
frequent single cause of death in cancer patients. Kern and Norton (1988), 
concluded that most cancer patients have clinically detectable cachexia. 
This is supported by Nixon et. al. (1980) who found widespread protein 
energy malnutrition (PEM) in cancer patients based on creatinine-height 
ratio. 
It is unclear whether the weight loss associated with cachexia is due to 
decreased caloric intake, increased energy requirements or a combination 
of the two. Numerous factors can be identified that may lead to anorexia 
and decreased caloric intake in oncology patients. These include intestinal 
obstruction or fistula formation, radiotherapy or chemotherapy induced 
nausea, vomiting, altered taste sensations, mucosal damage or anxiety 
(Fearon and Carter, 1988). Very few attempts have been made to 
accurately describe the energy and protein intakes of oncology patients. 
Holroyde and Reichard (1986) believe this is because of the limitations of 
retrospective dietary analysis and patient recall. They report that daily 
caloric intakes in groups of adult weight losing oncology patients have 
ranged from 4800-6500kJ in various studies. Unfortunately, the 
nutritional requirements of cancer patients are as yet unknown and hence 
any estimations of energy or protein intakes may only be compared to 
requirements for populations without cancer. 
Another possible reason for the weight loss seen in cachexia is an 
increased energy expenditure. Some studies (Lindmark et al, 1984) have 
shown increases in energy expenditure in oncology patients of 5-20%, 
others (Knox et al, 1983) have shown that some cancer patients are 
hypermetabolic (26%), some are hypometabolic (33%) and some have 
normal rates of metabolism (41%), still other studies have shown no 
difference between energy expenditure rates of cancer patients when 
compared to controls (Hansell et al., 1986). Clearly, more research needs 
to be done in this area, however it seems that cancer may have a marked 
effect on the host's metabolism and this may lead to an increased energy 
expenditure and contribute to weight loss. 
2.3 Effects of Radiotherapy 
2.3.1 Introduction 
Radiotherapy is the use of high energy radiation to treat malignant 
disease. Unfortunately, the area of treatment cannot be confined to the 
malignant target cells and some normal tissue will be effected. If these 
normal cells are in or near the gastrointestinal tract, nutritional 
consequences may result from their damage during treatment. The site of 
treatment is connected to the types of nutritionally related consequences 
that may result. Hence, in this study, the main sites of treatment likely to 
have some nutrition related consequences of radiotherapy are the head 
and neck, chest and abdomino-pelvic areas of the gastrointestinal tract. 
2.3.2 Head and Neck Patients 
Radiotherapy to areas of the head and neck create the most nutritionally 
compromising consequences of any treatment site. Localised effects of 
radiotherapy to the head and neck which may result in alterations to 
nutritional status are: sore throat leading to odynophagia (pain on 
swallowing), dysphagia (difficult swallowing), xerostomia (dry mouth), 
mucositis, anorexia (lack of appetite), hypogeusia (lack of taste) or 
dysgeusia (altered taste) and nausea (Donaldson, 1977, Kokal, 1985 & 
McAnena & Daly, 1986). The severity of these symptoms is related to the 
dose of radiation administered and the size of the area being radiated 
(Donaldson, 1977). 
The impairment that occurs with a patient's taste may begin as little as 
two weeks after beginning therapy (Kokal, 1985) and taste may gradually 
return over one year post therapy (Donaldson, 1977). It is believed to 
occur due to radiation damage of the microvilli of the taste cells or their 
surfaces (Conger, 1973 cited in Donaldson, 1977). It can be appreciated 
that as the sensation of taste disappears, the enjoyment of eating declines 
and consequently oral intake is likely to fall. 
Exposure of the salivary glands to radiation during treatment to the head 
and neck may also have nutritional consequences. Salivary excretion 
decreases and the secretion becomes thick and acidic (Donaldson, 1981). 
The decrease in saliva production may lead to dysphagia, especially of 
dry foods. The teeth are usually protected by a coating of saliva. When 
the amount of saliva produced is decreased, the teeth are more susceptible 
to bacterial attack leading to dental caries (Kokal, 1985). Dysphagia and 
accelerated rates of carie formation may also lead to decreased oral intake. 
A simple method to observe how a patient's nutritional status is altered by 
the consequences of radiotherapy to the head and neck mentioned above, 
is to monitor the weight of patients throughout therapy. This technique 
was used by Donaldson (1977), who found the average weight loss for 122 
patients undergoing radiotherapy for cancers of the head and neck for 
periods of six to eight weeks was 3.7 kg. Fourteen of the group (8.7 per 
cent) lost greater than 10 per cent of their initial body weight on 
completion of the therapy. Only 10 (8.2 per cent) of the group of 122 
patients remained stable or gained weight. It should be noted that these 
patients received no specific dietary treatment. 
Chencharick and Mossman (1983) studied 74 head and neck cancer 
patients undergoing radiotherapy. They found that 94 per cent of patients 
lost an average of five kilograms prior to therapy and that this weight loss 
did not change throughout therapy. In contrast to Donaldson's study, 
these patients received nutritional counselling throughout the 
radiotherapy. Also in this study a subjective questionnaire was completed 
by the patients throughout the treatment addressing issues such as 
occurrence of xerostomia, dysgeusia, anorexia and dysphagia. 
2.3.3 Chest Patients 
Radiotherapy is often used to treat patients with malignancies of the 
thoracic or chest area, commonly lung or breast cancers. Common side 
effects of radiotherapy to this area with possible nutritional sequelae are 
oesophagitis and dysphagia. Oesophageal stricture or fistula formation 
may appear as late consequences of radiotherapy (Donaldson, 1977 & 
Kokal, 1985). Complaints of dysphagia are reported to appear after two or 
three weeks with radiation dose levels of approximately 30 gray. The 
dysphagia may last for two weeks after radiotherapy has ceased 
(Donaldson, 1977). 
23.4 Abdomino-pelvic Patients 
Radiotherapy is often used to treat malignancies in the abdominal or 
pelvic areas. Common cancer types in these areas are small or large bowel 
malignancies, prostate or bladder cancer. The acute effects of 
radiotherapy to the abdomino-pelvic region are nausea, vomiting and 
diarrhoea (Donaldson, 1977 & Kokal, 1985). These symptoms may present 
on initiation of treatment and persist throughout treatment. Clearly, over 
the period of treatment these side-effects may lead to a decline in patient's 
nutritional status. 
Irradiation to the abdomino-pelvic area may lead to malabsorption of fat, 
carbohydrate and protein, as well as electrolyte and fluid disturbances 
(Kokal, 1985). Choloretic enteropathy may result from abdomino-pelvic 
irradiation. Choloretic enteropathy is characterised by a malabsorption of 
bile salts by the irradiated bowel, leading to malabsorption of fat and 
steatorrhoea. The resulting increase in bile salts in the colon will inhibit 
water absorption and stimulate colonic peristalsis, causing further fluid 
and electrolyte disturbances (Kokal, 1985). 
To measure alterations to nutritional status of patients undergoing 
radiotherapy to the abdomino-pelvic region, Donaldson (1977) again used 
weight loss as an indicator of declining nutritional status. She found that, 
in a group of 67 patients undergoing whole abdominal radiotherapy for 
non-Hodgkin's lymphoma over a six week period, 88 per cent of the 
patients encountered weight loss and the average weight loss was 3.8 kg. 
The most common radiation dose for this group was 45 Gray. Thirteen 
per cent of the patients lost greater than 10 per cent of their initial body 
weight. 
Long term complications of radiotherapy to the abdomino-pelvic region 
include intestinal obstruction, submucosal fibrosis, enteritis, colitis or 
fistula formation. These complications may appear months to years after 
the completion of radiotherapy and effect 0.5 to 15 per cent of patients 
(Kokal, 1985). 
2.4 Indicators of Nutritional Status in Oncology Patients 
2Arl Introdiirtion 
Because of the high likelihood of cancer patients being malnourished 
before treatment or becoming malnourished due to the effects of 
treatment, screening for nutritional related problems or risk of developing 
these problems is necessary. To effectively screen for these problems, 
indicators of nutritional status in oncology patients must be identified. 
Unfortunately, there is no one indicator of a patient's nutritional status. 
Many indicators have been developed and those that have been used to 
describe nutritional status in oncology patients are outlined below. The 
indicators described below are all tools to help the observer, whether it be 
a physician or dietitian, describe the nutritional status and likelihood of 
nutrition related problems of the patient. These indicators do not replace 
clinical judgment, which many observers believe to be the single most 
important assessment tool (Jeejeebhoy and Meguid, 1986, Baker, Detsky, 
et al., 1982 & Grant, Custer, et al., 1981). The indicators are attempts to 
describe a patient's condition in an objective manner and because of 
numerous methodological problems, cannot be solely relied on to assess a 
patient's nutritional status. 
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2,4.2 AnthropoTnetric Indicators 
Of the many anthropometric measures available, body weight is the 
easiest to measure, most widely used and often the most important 
indicator of a patient's nutritional status. Body weight can give an 
indication of nutritional stores such as body fat and protein (Grant, Custer 
et al., 1981). A patient's relative weight can be described by the Body 
Mass Index (BMI): 
Weight (kg) 
Height2(m) 
Definitions of body fatness using the BMI (NH&MRC, 1984) are: 
Very underweight < 18kg/m2 
Underweight 18-20kg/m2 
Acceptable weight 20-25kg/m2 
Overweight 25-30kg/m2 
Obese >30kg/m2 
Using the BMI may give an indication of a patient's nutritional reserves 
before and during treatment. In a recent study conducted by Carey (1992) 
investigating the effects of radiotherapy to the head and neck and pelvic 
regions it was found that prior to therapy 20% of patients had a BMI < 
20kg/m2 indicating suboptimal nutrition. After treatment the number of 
patients with a BMI < 20kg/m^ had not changed. 
BMI cannot describe any recent weight fluctuations the patient may have 
had and these may be much more important than the current weight-for-
height of the patient. Weight loss may be described in a number of ways, 
in kilograms or as a percentage of usual weight are two common methods. 
Most studies agree that a weight loss of greater than 10% of usual body 
weight is an indicator of nutrition related complications (Smith & Mullen, 
1991, Zador and Truswell, 1987 & Grant, Custer et al., 1981). 
Subcutaneous fat stores can be assessed using skinfold calipers and can 
accurately reflect total body fat stores. However, large variance in 
measurements taken between three different observers has been noted 
using this method and to be considered abnormal it is suggested that 
measurements be below the fifth percentile of normal (Jeejeebhoy and 
Meguid, 1986). Baker and colleagues (1982) found that clinical judgment 
was a better predictor of patient's outcome than triceps skinfold. 
The anthropometric indicators of skeletal muscle mass commonly used in 
oncology patients are mid-arm circumference (MAC) and mid-arm muscle 
circumference (MAMC). The MAMC is derived from a formula which 
includes triceps skinfold and MAC. MAC is measured with a tape 
measure and compared to tables of "normal" to determine the percentile 
of normal. This leads to two sources of error, first the error involved with 
attaining the measurement, secondly the error arising when comparing a 
single measurement to a sample of a population classified as "normal". 
Because of these errors patients can only be described as having an 
abnormal MAC if the measurement is less than the fifth percentile of 
normal. 
In Carey's study (1992) it was found that after 6 weeks of radiotherapy to 
the head and neck or pelvic regions the mean decrease in MAMC was 
0,384mm. To be able to detect a true change in arm muscle circumference 
calculated from MAC and triceps skinfolds. Hall and colleagues (1980) 
thought the change needed to be at least 2.68cm. Similarly, Macia and 
colleagues (1991) found that a group of head and neck cancer patients 
who underwent radiotherapy with an average dose of 61 Gray had a 
decrease in MAMC of only 1cm over the period of treatment, with no 
dietary intervention. 
2,43 Biochemical Indicators 
The most common biochemical indicators used in studies to describe the 
nutritional status of cancer patients are the serum proteins, albumin and 
transferrin. Both of these proteins are synthesised in the liver and the 
assumption is that depressed serum concentrations of the proteins is due 
to decreased biosynthesis by the liver as a result of lack of substrate 
associated with malnutrition (Grant, Custer, et al., 1981). In large 
population studies decreased albumin concentrations are associated with 
decreased dietary protein intakes. 
Gray and Meguid conducted a study in 1990 investigating 22 patients 
with cancer, who had initial serum albumin concentrations of <35g/L 
(normal 40-52g/L), who had been administered total parenteral nutrition 
(TPN) solutions providing an average of 197% of their predicted basal 
energy requirements and 1.54g/kg of protein per day for 21 days. Serum 
albumin and body weight were measured before and after the 21 days of 
TPN. Body weight over the 21 days increased from an average of 51kg to 
54kg, however serum albumin fell from 30.8g/L to 28.6g/L. Gray and 
Meguid concluded that low serum albumin in cancer patients is not 
reflective of their nutritional status, but is a consequence of the disease 
itself. 
Carey's study (1992) found no significant difference in patient's serum 
albumin or transferrin levels before and after six weeks of radiotherapy to 
the head and neck and pelvic areas with dietary counselling available. 
Macia et al. (1991) found a significant decrease in serum albumin and 
transferrin concentrations of patients undergoing radiotherapy to the head 
and neck after treatment with no dietary intervention but no difference in 
those that did receive dietary counselling throughout treatment. With 
patients receiving abdomino-pelvic irradiation, however, no significant 
difference was found in serum albumin or transferrin levels after 
treatment in both the group who received dietary counselling and those 
who did not. 
2,4.4 Clinica] Tndiratorft 
As mentioned above, many authors feel that clinical judgment is the most 
important assessment tool and may be more accurate at predicting 
complications than objective measurements (Baker et al., 1982). Clinical 
indicators of nutritional status are signs or symptoms that may present as 
a result of poor nutritional status or signs or symptoms of conditions that 
are likely to lead to a decline in the nutritional status of the patient. In 
cancer patients we know that these conditions may occur as a result of the 
disease itself or as a consequence of treatment. These indicators have been 
investigated in cancer patients usually by either objective examination by 
physicians or subjective questionnaires completed by the patient. 
Macia and colleagues (1991) had two doctors assess symptoms and signs 
in their study group of 93 oncology patients undergoing radiotherapy. 
They reported the presence of dysphagia, odinophagia, anorexia, 
diarrhoea, decreased oral intake, mucositis and radiodermatitis in patients 
undergoing radiotherapy to the head and neck, breast or abdomino-pelvic 
regions. They found 12 per cent and 43 per cent of head and neck patients 
suffered worsening dysphagia and odinophagia respectively with 
treatment, whilst none of the breast or abdomino-pelvic group had any 
worsening dysphagia or odinophagia. In the head and neck, breast and 
abdomino-pelvic groups, 61 per cent, 21 per cent and 59 per cent 
respectively suffered worsening anorexia. Fifty nine per cent of the 
abdomino-pelvic group suffered worsening diarrhoea. These results were 
from the control group who received no dietary counselling or 
intervention. 
Nayel and colleagues (1992) studied clinical indicators in head and neck 
cancer patients undergoing radiotherapy by subjective questionnaire 
dealing with xerostomia, dysgeusia, hypogeusia, dysphagia, anorexia and 
food preferences. The questionnaire was completed before the start of 
radiotherapy and at weekly intervals for six weeks during therapy. After 
four weeks (40 Gy) of therapy 91 per cent of patients complained of a dry 
mouth. Before radiotherapy 17 per cent of patients were aware of taste 
changes and a lack of appetite, after five weeks (50 Gy), 70 per cent were 
aware of these problems. Twenty two per cent of patients were aware of 
swallowing difficulties before therapy, after therapy 82 per cent 
complained of dysphagia. There was no significant difference in the 
number of complications patients were subjectively aware of between the 
group who received no oral nutritional supplementation and the group 
which did receive supplementation. 
Chencharick and Mossman (1983) also used a subjective questionnaire in 
head and neck radiotherapy patients to assess changes in clinical 
indicators of nutritional status with radiotherapy. They found 25 per cent 
of patients complained of dry mouth before radiotherapy and this number 
increased to 80 per cent by the fourth week of treatment. Fourteen per 
cent of patients reported taste changes before, by the fifth week 84 per 
cent complained of dysgeusia. Anorexia incidence increased from 20 per 
cent before therapy to 60 per cent after the fourth week of therapy. 
2.4.5 Diptary Indicators 
A declining nutritional status may be due to a decrease in the intake of 
energy or protein over a period of time. There are many tools available to 
describe a person's daily oral intake. These measurement tools usually 
depend on the subject's ability to recall intake or accurately record intake. 
Very few studies have attempted to accurately describe the usual daily 
oral intake of oncology patients. Those that have, relied on the 24 hour 
recall method of describing oral intake. 
Chencharick and Mossman (1983) took 24 hour dietary histories from 
eight patients after one week of radiotherapy and after six weeks of 
therapy. They found that early in therapy, patient's average daily energy 
intake was 7300 kilojoules. Late in therapy this had decreased to 7100 
kilojoules per day. The average protein intake at week one was 72g per 
day, whilst after six weeks of therapy it was 66g per day. 
Carey's 1992 study on head and neck and pelvic radiotherapy patients had 
24 hour dietary recalls taken from each patient at weekly intervals for six 
weeks. Protein intake fell from 74g per day in the first week of therapy to 
64g per day in the last week. The estimated protein requirement for the 
group was 86g per day. Average daily energy intake fell from 7610 
kilojoules to 5710 kilojoules over the six weeks of treatment. The average 
daily energy requirement for these patients was calculated to be 10,150 
kilojoules. This requirement was obtained from a 1979 paper by Long et 
al. who estimated requirements using indirect calorimetry and nitrogen 
balance. The requirements were not developed for cancer patients 
specifically. As already mentioned, cancer effects the host's metabolism in 
ways not fully understood and no daily energy or protein requirements 
have been specified for cancer patients at this time. 
2.5 Use of Alternative Treatments in Oncology Patients 
A study by Feigen and Tiver (1992) at Westmead Hospital showed that in 
a group of 202 cancer patients 27 per cent had used unconventional 
dietary supplements, consulted alternative health practitioners or both. 
Another 24 per cent of the group were using minor dietary modifications 
or low dose vitamin supplementation. Of those using major dietary 
supplements the most common types were high doses of vitamins, usually 
A, B, C and E and herbal extracts, mostly in the form of herbal tea. The 
most popular types of alternative practitioners were naturopaths, faith 
healers and meditation group leaders. 
The study found no consistent trend between the use of alternative and 
the type of conventional treatment received, the site or stage of their 
cancers, the patient's prognosis or the clinical course of the disease. 
Feigen and Tiver (1992) report that although there is strong 
epidemiological evidence that diet may be a factor in the aetiology of 
cancer, there is little evidence that changing diet after cancer has 
developed will change the course of the disease. Excessive doses of 
vitamins or other supplements may be toxic, may interfere with 
conventional treatment and confound diagnostic tests. To my knowledge 
there has been no study of this type conducted with cancer patients 
receiving radiotherapy. 
2.6 Selection of Diet Survey Methods 
To describe oral intake before and after radiotherapy, a 24 hour dietary 
recall was used. This was the preferred method of decribing patient's 
intakes in similar studies by Carey (1992) and Chencharick and Mossman 
(1983). The method was chosen primarily because of the speed and ease 
with which the survey could be completed. A study by Gersovitz, 
Madden and Wright (1978) showed that for a group of elderly subjects the 
24 hour recall gave a relatively valid estimate of their mean daily intake. 
There are several limitations with the use of the 24 hour recall method. It 
has been found that the method tends to overestimate low intakes and 
underestimate high intakes. There is also a danger of false negatives 
(failing to detect an actual difference between groups) when comparing 
dietary intakes of groups of people (Gersovitz, Madden, et al. (1978). 
Beaton and colleagues (1979) concluded that the precision of the estimate 
of an individual's usual intake based on one 24 hour recall, is relatively 
low. However if the focus of attention is on the mean intake of a group, as 
in this study, the low precision may not be as important as it is with 
observations of a single subject. 
2.7 Conclusion 
It is reasonably well established that patients presenting for radiotherapy 
for treatment of cancers of the gastrointestinal tract, especially those with 
head and neck cancers may have compromised nutritional status before 
beginning treatment. Radiotherapy to regions of the gastrointestinal tract 
can produce side effects that are likely to have an negative effect on the 
cancer patients's nutritional status. The aim of this study is to investigate 
the changes in nutritional status in patients undergoing radiotherapy by 
observing the changes in anthropometric, clinical and dietary indicators of 
nutritional status. 
Chapter 3 
Method 
Chapter 3 
Method 
Ethics 
Ethics approval was sought and granted by the University of Wollongong 
Human Experimentation Ethics Committee under Category 1.2: Collecting 
individually unidentifiable data by survey from informed consenting 
adults. No ethics approval was sought from St George Hospital after 
consultation with the Director of the CCC. It was felt that the study did 
not impede on the subjects enough to warrant attaining approval. All 
patients were fully informed and gave written consent to their 
participation in the study (refer appendix 1). 
Subjects 
The population for this study consisted of 45 consecutive patients that 
presented for radiotherapy planning at the St George Hospital CCC over a 
six week period. During the study two patients died. Three patients were 
missed when completing the final questionnaire due to sickness of the 
researcher. A total of 40 patients completed both initial and final 
questionnaires. One patient was excluded from the study because they 
were receiving radiotherapy to both head and neck and chest region. 
Fifty nine per cent (23) of the population were male, 41 per cent (16) were 
female. The population was divided into four main categories depending 
on the site of their treatment. There were three Head and Neck (HN) 
patients (8 per cent), 17 Abdomino-pelvic (AP) patients (43 per cent), 14 
Chest (C) patients (36 per cent) and five Other (O) patients (13 per cent). 
Only two patients initially approached refused to take part in the study. 
Research Dp îgn 
Subjects were approached when they presented for radiotherapy planning 
and asked if they would participate in the study. After completing the 
consent form (see appendix 1), the sole researcher read the questions on 
the initial questionnaire (see appendix 2) to the patient and recorded the 
answers on the questionnaire. This avoided any ambiguity with questions 
as the researcher was on hand to explain any questions which the patients 
found difficult. The questionnaire had been pilot tested on a small group 
of patients before the study was commenced and minor changes were 
made to its structure. After the questionnaire was completed, a 24 hour 
dietary recall with checklist was conducted, again with the researcher 
recording the patient's intake on an answer sheet (see appendix 3). The 
patient's height and weight were measured and recorded. The initial 
consult took between 10 to 15 minutes. 
Treatment usually commenced two to three days after the planning 
session. Subjects were seen again on or about their last day of treatment, 
usually four to six weeks after treatment commenced. On this occasion 
they were again weighed and asked to answer the second questionnaire 
(see appendix 4), which was read out by the researcher who also recorded 
the answers. A second 24 hour dietary recall was conducted and the 
results recorded by the researcher. The final consult took between five 
and ten minutes. At this stage patient contact ceased. 
It should be noted that approximately nine final consultations were 
conducted by telephone the week after the patients had finished their 
treatment, due to the researcher becoming ill. Patient's weights on or 
about their last day of treatment were obtained from nursing notes. 
Questions on the questionnaire as well as the 24 hour recall appeared to 
be understood and answered appropriately over the telephone by 
patients. 
Data Analysis 
The results of the 24 hour dietary recall were analysed using the "Diet 1" 
(NutTab 1992 database) Dietary Analysis Package. Daily intakes of 
energy (kj) and protein (g) were analysed and recorded. Statistical tests 
were used to determine if there were any differences between the four 
study group's demographics (including age, initial BMI and amount of 
radiation received) weight loss, energy and protein intake and symptoms 
following radiotherapy. The statistics were analysed using the JMP 
statistics package. All tests were carried out using parametric analysis of 
variance, where the distribution of scores were thought to be not normal, 
a non-parametric Wilcoxin-Signed Rank test was used. 
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Description of Study Groups 
HN* AP c O Total 
Number 3 17 14 5 39 
Male 2 16 3 2 23 
Female 1 1 11 3 16 
Age 57 69 58 51 61 
Initial BMI 31 28 27 26 27 
Gray 43 51 45 37 46 
Prior Treatment 2 11 10 5 28 
HN = Head and Neck, AP = Abdomino-pelvic, C = Chest, O = Other. 
Table 4.1. Description of Study Groups. 
Table 4.1 shows the number of patients in each study group, the 
distribution of gender, the group's average age, average BMI and average 
amount of radiation absorbed during treatment and the number from each 
group who had either surgery, chemotherapy, radiotherapy or some 
combination of the three before presenting for radiotherapy. 
From Table 4.1 we can see that the HN and O groups contain very small 
numbers and hence conclusions from results of these groups will be very 
difficult to make. The AP group is dominated by males usually with 
rectal or prostate cancer. The C group contains a majority of females 
usually with breast cancer (See appendix 5 for full breakdown of cancer 
sites among the study groups). 
The AP group appears to be older on average than the other groups, 
however. Analysis of Variation showed no significant difference between 
ages in all groups (F Ratio=2.35, Prob>F=0.09) (Prob>F must be <0.05 to be 
significant). There was also no significant difference between the initial 
BMIs of the groups (F Ratio=0.83, Prob>F=0.49). It was interesting to see 
that the average BMI of the groups before therapy exceeded the 
recommended level of 20-25kg/m2 and classified in the overweight range. 
Only two patients had a BMI of less than 20kg/m2 (i.e underweight), they 
were both females from the Chest group. The average radiation (Gray) 
absorbed by the patients in the groups over their periods of treatment 
was also not significantly different (F Ratio=2.53, Prob>F=0.07). 
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Figure 4.1. Weight Fluctuations Before and During Treatment. 
Figure 4.1 shows the weight fluctuations before treatment and during 
treatment of the four study groups as well as the study population as a 
whole. Subjects were asked what their weight was prior to being 
diagnosed with cancer in the initial questionnaire. From this weight was 
subtracted the weight obtained by the researcher at the initial consult to 
give the weight fluctuation before treatment. From Figure 4.1 it is obvious 
that the HN group had lost by far the most weight before treatment. 
Overall, the AP group had actually put on an average of one kilogram 
from the pre-diagnosis weight they gave. The C and O groups and the 
group as a whole had no fluctuation in weight before therapy. 
During their treatment the group as a whole lost an average of 0.4kg. On 
average, the AP group lost 0.7kg, the C group lost 0.3kg, the HN group 
had the largest weight fluctuation of -1.7kg and the O group actually put 
on 1.1kg overall over their course of treatment. In order to see if there was 
any difference in weight due to treatment, an analysis of variance with 
weight before treatment was carried out. No significant difference in 
weight fluctuations during treatment was found between each group (F 
Ratio=2.2, Prob>F=0.087). 
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Figure 4.2 Weight Loss Before and During Treatment 
Figure 4.2 shows the number of patients in eac±i group who had weight 
loss before and during treatment and the average amount of weight loss 
in each study group. Before treatment, three (100 per cent) of the HN 
group had lost an average of 6.7kg. Seven (41 per cent) and six (43 per 
cent) patients in the AP and C groups had lost an average of 3.0kg and 
2.6kg respectively before treatment. During treatment the HN group had 
the largest weight loss with two (67 per cent) of the subjects losing an 
average of 2.5kg each. The AP group had the next largest weight loss 
with eight (47 per cent) of the patients losing 2.3kg each. Seven of the C 
group lost an average of 1.4kg each during treatment. Three (60 per cent) 
of the O group had lost 3.4kg before treatment, however none of the O 
group lost any weight during treatment. 
Reported Sidp Fffprtc; of Trpafmpnt 
Appendix 6 contains full analysis of the side effects reported by the HN, 
AP and C groups before and after treatment. The Other group was not 
included in these analyses because side effects reported by this group 
cannot be attributed to the effects of radiation on the gastrointestinal tract. 
Two side effects were found to be significantly different between groups. 
The first was diarrhoea where 13 patients (76 per cent) in the AP group 
complained of diarrhoea after treatment. This was significantly higher 
than any other group (F Ratio=10.52, Prob>F=0.00). The other reported 
side effect of significance was dysphagia. Before treatment none of the C 
group had reported dysphagia. After treatment, seven of the C group (50 
per cent) reported dysphagia which was significantly higher than the 
other groups, except the HN group (F Ratio=4.95, Prob>F=0.01). 
Supplement Use 
Patients were asked if they were using any dietary supplement at the time 
of treatment. Supplements commonly used were vitamins, usually B or 
C, herbs such as garlic or herbal tea. Three patients were drinking 
Sustagen or a similar high protein, high energy supplement. Overall 18 of 
the group (46 per cent) were using some dietary supplement. 
Study Group No. Using Siipplpmpnt (Perceni-agp of Grmip) 
Head and Neck 0/3 (0 per cent) 
Chest 9/14 (64 per cent) 
Abdomino-pelvic 6/17 (35 per cent) 
Other 3/5 (60 per cent) 
Table 4.2 Supplement Use Among Study Groups. 
Table 4.2 shows the use of dietary supplements among the study groups 
during treatment. From Table 4.2 we can see that the Chest group has the 
greater percentage of patients using some dietary supplement. Compared 
to the abdomino-pelvic group, these patients were typically younger, 
female and tended to be more liberal in their use of vitamin and herbal 
supplements. 
Energy and Protein Fluctuations with Treatment. 
HNi AE C Q 
Initial Energy 7250 8600 6200 6300 
Intake (kj/d) 
Final Energy 6950 8000 6050 5800 
Intake (kJ/d) 
Difference (kJ/d) -300 -600 -150 -500 
HN = Head and Neck, AP = Abdomino-pelvic, C = Chest, O = Other. 
Figure 4.3 Energy Fluctuations with Treatment. 
Figure 4.3 shows the average daily energy intake of the four study groups 
before beginning radiotherapy, after radiotherapy had ceased and the 
difference between the two intakes. All groups consumed less energy 
after treatment had ceased than before radiotherapy commenced, 
however, none of these decreases in intake were statistically significant (F 
Ratio=0.35, Prob>F=0.79). 
Although there are no specific daily dietary requirements set for oncology 
patients, it is interesting to compare the above results, especially of the AP 
and C groups, to the Australian Recommended Daily Intakes (RDI) for 
men over 64 years (the bulk of the AP group) and women over 54 years 
(the majority of the C group) as described by the National Health and 
Medical Research Council. The RDI of energy for men over 64 years is 
10,600 kj and for women over 54 years, 8,000 kj. Both the AP and the C 
group consumed less energy than the RDI before and after treatment. 
UN* AE c a 
Initial Protein 63 90 62 68 
Intake (g/d) 
Final Protein 72 79 62 66 
Intake (g/d) 
Difference (g/d) 9 -11 0 -2 
*HN = Head and Neck, AP = Abdomino-pelvic, C = Chest, O = Other. 
Table 4.4 Protein Fluctuations with Treatment. 
Figure 4.4 shows the average daily amount of protein consumed by each 
group before treatment, after treatment and the difference between the 
two. Compared to the RDI of protein for men over 64 years of 55g per day 
and for women over 54 years of 45g per day, the AP and C group are 
consuming more protein than is deemed necessary by the NH&MRC. The 
differences between the protein intakes before and after treatment in all 
study groups are very small. 
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Anthropomeirir indicators 
If nutritional status was measured using the Body Mass Index (BMI) 
alone, this sample of radiotherapy patients would be classified as having 
good nutritional status due to oz^^rconsumption, not necessarily what one 
would expect in a group of people with cancer. The mean BMI for the 
study population was 27kg/m2, thus, the study population appears to 
have large nutritional reserves. This result falls between results in two 
other similar studies. Macia and colleagues (1991) found abdomino-pelvic 
and breast groups had an average BMI of SOkg/m^ before treatment. The 
1992 study by Carey, found the average BMI of her study population, 
made up of 20 head and neck and pelvic radiotherapy patients, was 
24kg/m^ before treatment. 
Only two out of the 39 patients (5 per cent) in this study had a BMI less 
than 20kg/m2 i.e. were classified as underweight. In contrast, four of 20 
patients (20 per cent) in Carey's study had a BMI of less than 20kg/m2 
when starting treatment. There is obviously some difference between the 
two populations. Probably the main difference is that, this study 
investigated all patients presenting for radiotherapy, not only those 
receiving treatment for HN or AP cancers. 
As a group, the population of this study had no decrease in weight prior 
to their diagnoses with cancer until the time they started treatment. Thus, 
on average, their weight had been stable for some time. After treatment, 
the group had lost an average of 0.4kg. Nineteen of the study population 
(49 per cent) had lost weight before treatment, with the average loss being 
3.5kg. During treatment, 17 of the group (44 per cent) lost weight with the 
average loss being 2.0kg. 
Donaldson (1977) found 92 per cent of 122 HN patients lost an average of 
3.7 kg during six to eight weeks of radiotherapy. Chencharick and 
Mossman (1983) found that their group of 74 HN patients had an average 
weight loss of 5 kg before treatment and this weight loss did not change 
during treatment. It is difficult to compare these results to this study 
where 67 per cent of the group (2 patients) lost an average of 6.7kg before 
and 2.5kg during treatment due to the very small size of the HN group. 
The result in the AP group compares more closely with Donaldson's 
study, where the 88 per cent of the AP group lost an average of 3.8kg 
compared to 47 per cent per cent of the AP group losing 2.3kg in this 
study. Had numbers in the groups been closer, there were 67 in 
Donaldson's study, 17 in this study, the results may have been in more 
agreeance. 
Donaldsons's study was conducted in 1979 (and is still the most 
comprehensive of its type), and no patient received any dietary 
intervention. At the St George Cancer Care Centre nutrition advice is now 
an integral part of the patient's care and this, along with improved 
methods of treatment may lead to less weight loss in radiotherapy 
patients now than over a decade ago. 
If we now took weight loss as the sole indicator of nutritional status, then 
this study population appears to have had good nutritional status before 
radiotherapy and this c±ianged little with therapy. Certainly no patient 
lost greater than ten per cent of their body weight, the level at which most 
authors agree (Smith & Mullen, 1991, Zador and Truswell, 1987 & Grant, 
Custer et al., 1981) demands dietary intervention, during therapy and 
only two had lost greater than ten per cent (10.4 and 11.8 per cent) before 
treatment, however this was based on the patient's recall of their weight 
before diagnosis of cancer. 
Clinical Indicators 
There is substantial evidence that patients experience significant 
nutritional problems as a result of cancer and that radiotherapy and other 
cancer treatments may exacerbate these problems. Subjective 
questionnaires have been used to identify these problems in HN patients 
undergoing radiotherapy (Nayel et al., 1992, Chencharick and Mossman, 
1983). A subjective questionnaire was used in this study to identify 
changes in these clinical indicators of nutritional status. 
Very few comparisons can be made between the results of the subjective 
reports of side effects of the HN group in this and the two studies 
mentioned above because of the small number of patients in the HN 
group. If the group was larger, however, we would expect the HN group 
to complain of side effects in a manner that reflects the findings of the 
studies done in this area. That is, we would expect a percentage of the 
subjects to have swallowing difficulties, anorexia and some taste changes 
before therapy, and these percentages would increase markedly with 
treatment. Xerostomia, which may not be present before radiotherapy 
would probably effect 80 to 90 per cent of patients at some time during 
treatment (Nayel et al., 1992, Chencharick and Mossman, 1983). 
Macia and colleagues (1991) found that in a group of abdomino-pelvic 
patients undergoing radiotherapy, 59 per cent had worsening anorexia, 59 
per cent had worsening diarrhoea and there were no complaints of 
dysphagia during treatment. The results of this study compare well with 
Macia's findings in that the number of patients in the AP group 
complaining of diarrhoea increased from two before treatment to 13 after 
treatment, therefore 65 per cent of the group had worsening diarrhoea. 
There were also no complaints of dysphagia before or after treatment in 
the AP group and none were expected given the area in which the 
radiation was absorbed. Complaints of anorexia did rise from three 
before treatment to five after but this was not reflective of the increase in 
lack of appetite that Macia found. This was perhaps due to the fact that 
none of the group in Macia's study received any dietary intervention and 
six of the AP group in this study had been referred to the oncology 
dietitian during the course of their treatment. 
The most significant clinical indicator of nutritional status that appeared 
during treatment in the C group was dysphagia. In Macia's study, a 
group of breast cancer patients had no complaints of dysphagia during 
radiotherapy. Dysphagia is not necessarily expected in breast cancer 
patients as the field that is irradiated does not usually include the 
oesophagus. In the C group in this study, which was 64 per cent breast 
cancer patients, seven (50 per cent) of the patients complained of 
dysphagia after treatment, with no dysphagia reported before treatment. 
Of the nine breast cancer patients in the group, two (22 per cent) reported 
dysphagia after treatment. 
It would be interesting to have a larger population of breast cancer 
patients to see if this trend is consistent. If it is, questions would have to 
be raised about the placement of treatment fields in the breast cancer 
patients, as we would not anticipate 22 per cent of the women with breast 
cancer undergoing radiotherapy to develop dysphagia. 
Of the HN, AP and C study groups, it appears that the HN group is likely 
to suffer the greatest decline in nutritional status due to clinical factors 
such as anorexia, xerostomia, dysphagia and dysgeusia however the 
results of this study, because of the small numbers in the HN group 
cannot be used to add weight to this argument. 
Patients receiving radiotherapy to the abdomino-pelvic area are likely to 
develop diarrhoea during treatment. This was shown in this study and 
adds weight to the arguments in the literature. Diarrhoea in these patients 
may be an indicator of declining nutritional status as malabsorption of fat 
and other nutrients is likely to occur (Kokal, 1985). 
Patients receiving radiation to the c±iest area, especially those with lung 
cancer, are likely to develop dysphagia during treatment as a result of the 
proximity of the treatment field to the oesophagus and the consequent 
effect of radiation on the mucosa of the oesophagus (Donaldson, 1977). 
This was supported by this study and it was also found that two of nine 
breast cancer patients developed dysphagia with treatment. This was not 
expected, as the treatment field in breast cancer would not be expected to 
include any part of the oesophagus. Dysphagia has an obvious 
detrimental effect on nutritional status by limiting patient's food intake. 
Dietary Indicators 
The energy and protein fluctuations seen in this study from before 
treatment to after treatment, although indicating a downward trend, were 
not significant. Carey (1992) found the average daily energy and protein 
intake in a group of HN and AP patients before radiotherapy was 7600kJ 
and 74g respectively. This compares closely with the results from this 
study where the average daily energy and protein intakes for the study 
population as a whole before treatment were 7350kJ and 75g respectively. 
Both studies used the 24 hour dietary recall method to obtain these results. 
There are no dietary requirements established for cancer patients at this 
time but when compared to the Australian RDIs the patients in this study 
were consuming significantly less energy than recommended. Usually, 
this would mean that the population would be losing weight due to poor 
energy intake. However it was found that this population had stable 
weight for some time prior to treatment. This apparent contradiction is 
probably best explained by the data collection method, i.e. the 24 hour 
dietary recall, not accurately describing the individual's usual intake. It 
may also be due to the effects of cancer on the metabolism of the host 
which are not fully understood at this time. 
If a declirung oral intake is indicative of a declining nutritional status in 
cancer patients, then one would have to say that radiotherapy had little 
effect on the intake and hence the nutritional status of the patients in this 
study using the 24 hour recall method to describe intake. 
Supplement Use 
Use of supplements may or may not effect the nutritional status of a 
cancer patient. However, it is helpful for nutrition professionals to know 
the incidence of supplement use among cancer patients. In this study, 
patients in the C group were the biggest users of supplements which were 
commonly doses of the "antioxidant" vitamins, A,C and E, or herbal 
preparations such as teas or garlic tablets. 
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The nutritional status of a cancer patient is effected by many things. In 
this study anthropometric, clinical and dietary indicators of nutritional 
status were used to try and determine if radiotherapy made any 
difference to the nutritional status of the patient, or if nutritional status 
differed between groups of patients receiving radiotherapy to different 
regions of the gastrointestinal tract. This study found that anthropometric 
and dietary indicators of nutritional status did not indicate poor 
nutritional status in this group of subjects and did not change significantly 
with treatment. The results of this study show that clinical indicators of 
nutritional status that were subjectively reported by patients after 
treatment had ceased, were most important in detecting possible declines 
in nutritional status. 
The significant difference between the two largest study groups in these 
clinical indicators was that abdomino-pelvic patients are likely to develop 
diarrhoea during treatment and patients undergoing radiotherapy to the 
chest area are likely to develop dysphagia during treatment. Both 
dysphagia and diarrhoea may lead to declines in nutritional status. 
Patients receiving radiotherapy to the head and neck area are likely to 
develop numerous clinical indicators of declining nutritional status 
during treatment, however, due to the small number of subjects in this 
group of tiie study, no weight can be added to the argument present in the 
literature. 
Recommendations 
Future research in this area should take into consideration a number of 
recommendations. Firstly, strive for as large a population size as possible. 
Whilst the AP and C groups in this study had just sufficient numbers to 
draw meaningful results from, the HN group certainly did not. This was 
disappointing as most of the research in this area had been done using 
head and neck cancer patients. 
The use of a 24 hour dietary recall to obtain usual daily intakes of patients, 
whilst quick and easy to carry out, should be discouraged. I believe a 
three day food record would be significantly more accurate and may 
produce a result that does show a significant difference in intakes before 
and after treatment. 
Try to evaluate as many indicators of nutritional status as possible. The 
major omissions from this study were biochemical measures such as 
serum proteins. The more indicators that are evaluated, the clearer the 
overall picture one will obtain of the actual nutritional status of the 
patient. 
Limitations of the Study 
1. Small sample size in some study groups such as the HN and O 
groups made it difficult to draw meaningful results from these groups 
and impossible to compare them with other studies. 
2. Use of 24 hour dietary recall to estimate energy and protein intakes 
before and after treatment. Use of a three day food record may have 
yielded a much more accurate result. 
3. No food models were used during the 24 hour recall to more 
accurately judge the actual amounts of food consumed. 
4. No biochemical indicators of nutritional status such as serum 
albumin or transferrin were used in this study because they were not 
routinely obtainable from the patients in this setting. 
5. Data entry errors. When entering food intake data into the Diet 1 
software package, various assumptions had to be made when full details 
of a particular food were not given. 
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Appendix 1 
CONSENT FORM 
NUTRITION STUDY IN ONCOLOGY PATIENTS 
This research is being conducted as part of a Master of Science (Nutrition and Dietetics) 
degree at the University of WoUongong under the supervision of Ms J McArthur. The 
aim of the study is to determine how an oncology patient's nutritional status is altered 
after undergoing radiotherapy. 
I agree to participate in this study. I understand that it requires a survey to be completed, 
my height and weight to be measured and a dietary record to be taken. 
Participation or non participation will not effect the treatment that I receive now or in the 
future. If at any time I wish to cease participation I understand that I am able to do so. 
Any enquiries regarding conduct of research may be forwarded to: 
The Secretary 
University of WoUongong 
Human Experimentation Ethics Committee 
Telephone: (042) 213079 
Signature 
Date: 
Appendix 2 
MRN. 
NUTRITIONAL STATUS SURVEY (1) 
Have you ever had any of the following treatments for cancer? 
Radiotherapy • 
Chemotherapy • 
Surgery • 
Other • Please Describe 
No • 
Have you ever seen a dietitian before? 
No n 
Yes • When? 
Why 
Have you ever sought or been given dietary advice from anyone other than a dietitian (eg 
Doctor, Naturopath, books, etc)? 
No n 
Yes • Doctor • Wt. Loss Centre • 
Naturopath • Friend • 
Books n Other • 
Would you describe your appetite now as: 
Good • 
Fair • 
Poor • 
Since being diagnosed with cancer, has your appetite been: 
Remaining Stable • 
Increasing • 
Decreasing • 
Are there any foods which you find difficult to eat in any of the following food groups? 
Fruit & Vegetables • Meat & Meat Products • 
Breads & Cereals • Fats & Oils • 
Milk & Dairy Products • No • 
Other n 
In which of the following food groups have you detected any taste changes? 
Fruit & Vegetables • Meat & Meat Products • 
Breads & Cereals • Fats & Oils • 
Milk & Dairy Products • No • 
Other n 
Are there any particular foods or food groups you avoid in your diet? 
Fruit & Vegetables • Meat & Meat Products • 
Breads & Cereals • Fats & Oils • 
Milk & Dairy Products • No • 
Other • 
Have you used any methods to change the consistency of any of your foods? 
Mincing • Thickening • 
Pureeing n Mashing • 
Juicing • No • 
Other n 
Are you taking any regular dietary supplements? 
No • Skim Milk Powder • 
Vitamins • Canned Supplements a 
Minerals • Amino Acids a 
Herb Preps • Others • 
Sustagen n 
Since being diagnosed with cancer: 
Do you have any feelings of nausea? 
Never • 
To what extent does this 
interfere with the enjoyment 
of your life? 
Sometimes • 
Often • 0 
1 1 1 1 1 i 1 1 I 
10 
Alwa}^ • Not at all Intense Interference 
Do you have any episodes of vomiting? 
Never D 
Sometimes • 
Often • 
Mways a 
0 10 
Not at all Intense Interference 
Do you have any episodes of diarrhoea? 
Never • 
Sometimes • 
Often • 
Always • 
0 
i I I I 
Not at all 
10 
Intense Interference 
Do you have any episodes of constipation? 
Never • 
Sometimes O 
Often • 
Always G 
0 
i I I I 
Not at all 
10 
Intense Interference 
Do you have any difRculty swallowing foods? 
Never • 
Sometimes O 
Often • 
Always D 
Do you have feelings of a diy mouth? 
Never • 
Sometimes D 
Often • 
Always • 
Do you experience a lack of appetite? 
Never C3 
Sometimes • 
Often • 
Always a 
0 
Not at all 
10 
Intense Interference 
0 
Not at all 
I l _ l 
10 
Intense Interference 
0 
I—I—I 
Not at all 
10 
_ l — l _ l — I 
Intense Interference 
Appendix 3 
MRN. 
24 HOUR DIETARY RECALL (1) 
BREAKFAST MORNING TEA 
LUNCH AFTERNOON TEA 
TEA SUPPER 
CHECKLIST 
A. Red meat. White meat. Milk. Cheese. Eggs. Fish. Legumes. 
B. Free Vegetables, Fruit - Fresh, Dried. Juice. 
C. Potato/Rice/Pasta, Bread, Cereals, Biscuits, Cakes. 
D. Butter/Margarine, Cream, Oil, Salad Dressings. 
E. Chocolates, Lollies, Icecream, Desserts. 
F. Drinks - Alcohol, Soft drinks. Cordial, Water, Tea, Coffee 
Activity Level?. 
Appendix 4 
MRN. 
NUTRITIONAL STATUS SURVEY (2) 
Would you describe your appetite now as: 
Good • 
Fair • 
Poor n 
Since commencing radiotherapy, 
has your appetite been: 
Remaining Stable • 
Increasing • 
Decreasing O 
Are there any foods which you find difficult to eat in any of the following food groups? 
Fruit & Vegetables • Meat & Meat Products • 
Breads & Cereals • Fats & Oils • 
Milk & Daily Products • No d 
Other • 
In which of the following food groups have you detected any taste changes? 
Fruit & Vegetables • Meat & Meat Products • 
Breads & Cereals • Fats & Oils • 
Milk & Daily Products • No O 
Other CJ 
Are there any particular foods or food groups you avoid in your diet? 
Fruit & Vegetables • Meat & Meat Products • 
Breads & Cereals • Fats & Oils • 
Milk & Daily Products • No • 
Other n 
Have you used any methods to change the consistency of any of your foods? 
Mincing • Thickening • 
Pureeing • Mashing • 
Juicing • No a 
Other • 
Are you taking any regular dietary supplements? 
No 
Vitamins 
Minerals 
Herb Preps 
Sustagen 
• Skim Milk Powder • 
• Canned Supplements • 
• Amino Acids • 
• Others • 
• 
Do you have any feelings of nausea? 
Never • 
Sometimes O 
Often • 
Alwajrs • 
To what extent does this 
interfere with the enjoyment 
of your life? 
0 10 
Not at all 
I I I ! 
Intense Interference 
Do you have any episodes of vomiting? 
Never O 
Sometimes D 
Often n 
Always • 
0 10 
Not at all Intense Interference 
Do you have any episodes of diarrhoea? 
Never • 
Sometimes • 
Often n 
Always O 
Do you have any episodes of constipation? 
Never D 
Sometimes n 
Often • 
Always • 
0 
Not at all 
10 
Intense Interference 
0 
Not at all 
10 
Intense Interference 
Do you have any difficulty swallowing foods? 
Never • 
Sometimes • 
Often • 
Always G 
To what extent does this 
interfere with the enjoyment 
of your life? 
0 
I I I i I 
Not at all 
10 
Intense Interference 
Do you have feelings of a dry mouth? 
Never G 
Sometimes O 
Often • 
Always • 
0 
Not at all 
10 
Intense Interference 
Do you experience a lack of appetite? 
Never O 
Sometimes O 
Often • 
Always D 
0 
Not at all 
i I I I 
10 
Intense Interference 
Appendix 5 
Distribution by Cancer Site. 
Breast 8 
Rectum 8 
Prostate 5 
Lung 4 
Tonsil 1 
Sigmoid 1 
Minimantle 1 
Femur 1 
Endometrium 1 
Chest Wall 1 
Bladder 1 
Back 1 
Arm/Hip 1 
Abdomen 1 
Groin 2 
Brain 2 
Total Patients = 39 
Appendix 6 
Nausea 
Head & Neck (3) Chest (14) Abdomino-pelvic (17) 
Study Group (No. in Group) 
M Before Treatment • After Treatment 
Diarrhoea 
Head & Neck (3) Chest (14) Abdomino-pelvic (17) 
Study Group (No. in Group) 
H Before Treatment • After Treatment 
Dysphagia 
Head & Neck (3) Chest (14) Abdomino-pelvic (17) 
Study Group (No. in Group) 
M Before Treatment • After Treatment 
Anorexia 
Head & Neck (3) Chest (14) Abdomino-pelvic (17) 
Study Group (No. in Group) 
H Before Treatment • After Treatment 
Xerostomia 
Head and Neck (3) Chest (14) Abdomino-pelvic (17) 
Study Group (No. in Group) 
0 Before Treatment • After Treatment 
Taste Changes with Therapy 
0 
Head & Neck (3) Chest (14) Abdomino-pelvic (17) 
Study Group (No. in Group) 
M B e f o r e Treatment • After Treatment 
Food Avoidance with Therapy 
Head & Neck (3) Chest (14) Abdomino-pelvic (17) 
Study Group (No. in Group) 
i l Before Treatment • After Treatment 
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